Where to Buy Medical Cannabis for Glaucoma: Buyer's Guide
Buy medical cannabis for glaucoma at state-licensed dispensaries or licensed delivery with a valid card. Compare products, check lab tests, avoid illegal sellers.
The best medical cannabis strains for glaucoma are THC-dominant cultivars such as Chemdawg, Jack Herer, OG Kush, Sour Diesel and Granddaddy Purple. THC is the cannabinoid tied to the short-term drop in intraocular pressure (IOP), so high-CBD, low-THC flower is a poor fit for this condition. Cannabis does not replace prescription eye drops, and any pressure change lasts roughly one to two hours.
THC acts on CB1 receptors in the eye and ciliary body and produces a measurable IOP drop that peaks about 60 to 90 minutes after inhaling and fades within two hours. CBD does not lower eye pressure on its own and can interfere with THC at the CB1 receptor, so a 1:1 or CBD-heavy product usually works against the goal. Strains bred for high THC with low CBD content dominate glaucoma conversations for that reason.
Cannabis for Glaucoma vs Traditional Medicine: What Actually Works
Five cultivars come up most among patients who track pressure and effects. Each is THC-dominant, stocked in most US dispensaries, and consistent enough to dose the same way twice.
Glaucoma Cannabis Treatment Cost: What Patients Actually Pay
Chemdawg carries 19 to 25 percent THC with a sharp diesel and pine profile. It pairs a fast cerebral onset with a relaxed body finish, which suits daytime dosing. Users who dislike heavy sedation tend to rank it first.
Jack Herer runs 18 to 23 percent THC and delivers clear-headed energy with almost no couch lock. The pine and spice aroma is mild, so it works for people who find fuel-heavy strains harsh. Best for morning or early afternoon use.
OG Kush tests 20 to 26 percent THC and blends cerebral lift with deep physical calm. It is the middle ground for anyone who wants THC strength without a racing head. Best for late afternoon and evening.
Sour Diesel sits at 20 to 25 percent THC with an energizing, sharp effect and a strong fuel scent. It appeals to patients who want alertness rather than relief from tension. Best for daytime use when fatigue is a problem.
Granddaddy Purple lands at 17 to 23 percent THC with grape and berry notes and a heavy indica finish. It is the pick when sleep and muscle relaxation matter more than daytime function. Best taken a few hours before bed.
High-CBD flower is useful for anxiety, inflammation and seizure disorders, but it does not lower eye pressure. A strain with 15 percent CBD and 4 percent THC gives you the sedating and calming effects without the CB1 activity that moves IOP. If pressure control is the goal, that trade-off rarely makes sense.
No. The American Academy of Ophthalmology and the National Eye Institute both note that cannabis lowers IOP for only one to two hours, which would require dosing many times a day to match the round-the-clock control of a daily prostaglandin drop. Untreated pressure damages the optic nerve permanently, so cannabis belongs beside standard therapy, never in place of it. Tell your ophthalmologist about any cannabis use before you change a treatment plan.
Strain names matter less than THC content and dose. A 25 percent THC flower taken in a full dose will typically move pressure more than a 15 percent strain, but the effect still lasts under two hours.
Neither label predicts IOP response, since the CB1 activity comes from THC itself. Choose sativa or indica based on whether you want alertness or sedation during the window when pressure drops.
Inhaled cannabis acts fastest, which matters for a short-lived effect. Smoke irritates the lungs and eyes, so vaporizing dry flower or using a measured oil is easier on the body over repeated daily doses.